MET and adenocarcinoma: [50], and is associated with high Ki67 in invasive cancers [51]. Increased expression of CCNB1 in NSCLC was suggested as a poor prognostic parameter [52], [53], [54]. CCNB2 and c-MET are also over expressed in adenocarcinomas [55], [56], [57], [58].